comparemela.com

Latest Breaking News On - Ibrosis - Page 4 : comparemela.com

Dietary carotenoids may reduce risk of non-alcoholic fatty liver disease, study suggests

Study found no direct link between total dietary vitamin A intake and non-alcoholic fatty liver disease (NAFLD) risk, but observed an inverse correlation between provitamin A carotenoid consumption and NAFLD risk.

United-states
Americans
Priyom-bose
Nutrition-examination-survey
National-center
Centers-for-disease
Health-statistics
National-health
Scientific-reportsstudy
Image-credit
Disease-control
Fatty-liver

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

Oxitope-pharma
Calluna-pharma
Calluna-pharmajan
Calluna-pharma-inc
From-calluna-pharmajan
Arxx-therapeutics
Chief-executive-officer
Antibodies
Ntibody
Hronic
Efficacy
Ibrosis

Groundbreaking study identifies FAM3C as a key regulator of breast cancer progression

A groundbreaking study conducted by Professor Jiyoung Park and her research team in the Department of Biological Sciences at UNIST has identified FAM3C, a metabolism-regulating signaling molecule produced by cancer-associated adipocytes (CAAs), as a key regulator of breast cancer progression within the tumor microenvironment (TME).

South-korea
Republic-of-korea
Korea
Cancer-research
Cancer-research-on
National-research-foundation-of-korea
Ulsan-national-institute-of-science
Ministry-of-science
Ministry-of-health-welfare
Korea-health-industry-development-institute
Department-of-biological-sciences

vimarsana © 2020. All Rights Reserved.